Symptoms
Common signs and symptoms of Ovarian Cancer (Epithelial) include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Ovarian Cancer (Epithelial).
Epithelial ovarian cancer develops when normal cells in the ovaries or fallopian tubes undergo genetic changes that cause them to grow uncontrollably.
Epithelial ovarian cancer develops when normal cells in the ovaries or fallopian tubes undergo genetic changes that cause them to grow uncontrollably. Scientists now believe that many cases actually start in the fallopian tubes, where cells become damaged and eventually spread to the ovaries. The exact trigger for these cellular changes remains unclear, but researchers have identified several factors that increase the likelihood of DNA damage occurring.
Hormone exposure plays a significant role in cancer development.
Hormone exposure plays a significant role in cancer development. Each time a woman ovulates, the surface of the ovary breaks to release an egg, then repairs itself. This repeated process of damage and repair over many years may increase the chance of cellular errors. This explains why factors that reduce lifetime ovulation - like pregnancy, breastfeeding, and birth control pills - tend to lower cancer risk.
Genetic factors contribute substantially to epithelial ovarian cancer risk.
Genetic factors contribute substantially to epithelial ovarian cancer risk. Inherited mutations in genes like BRCA1, BRCA2, Lynch syndrome genes, and others can dramatically increase a woman's lifetime risk. These genetic changes can be passed down through families and affect the body's ability to repair damaged DNA effectively. Environmental factors, age-related cellular changes, and inflammation may also contribute to cancer development, though their exact roles continue to be studied.
Risk Factors
- Age over 50, especially between 55-75 years
- BRCA1 or BRCA2 gene mutations
- Strong family history of ovarian or breast cancer
- Lynch syndrome or other hereditary cancer syndromes
- Personal history of breast, uterine, or colorectal cancer
- Never having been pregnant
- Infertility or difficulty conceiving
- Hormone replacement therapy after menopause
- Endometriosis diagnosis
- Ashkenazi Jewish ancestry
Diagnosis
How healthcare professionals diagnose Ovarian Cancer (Epithelial):
- 1
Diagnosing epithelial ovarian cancer often begins when a woman reports persistent symptoms to her doctor.
Diagnosing epithelial ovarian cancer often begins when a woman reports persistent symptoms to her doctor. Because early symptoms can mimic common digestive issues, doctors typically start with a thorough medical history and physical exam, including a pelvic examination. If ovarian cancer is suspected, the next step usually involves imaging tests and blood work to gather more information about what might be causing the symptoms.
- 2
The CA-125 blood test measures a protein that's often elevated in women with ovarian cancer, though it can also be high due to other conditions like endometriosis or even menstruation.
The CA-125 blood test measures a protein that's often elevated in women with ovarian cancer, though it can also be high due to other conditions like endometriosis or even menstruation. Imaging studies such as transvaginal ultrasound, CT scans, or MRI help doctors visualize the ovaries and surrounding structures. These tests can reveal masses, fluid accumulation, or other changes that suggest cancer, but they can't definitively diagnose it.
- 3
The only way to confirm epithelial ovarian cancer is through tissue analysis, either from a biopsy or surgical removal of the suspicious tissue.
The only way to confirm epithelial ovarian cancer is through tissue analysis, either from a biopsy or surgical removal of the suspicious tissue. In many cases, doctors recommend surgery both to diagnose and treat the cancer simultaneously. During this procedure, called staging surgery, the surgeon removes the ovaries, examines the abdomen thoroughly, and takes tissue samples to determine how far the cancer has spread. This information helps determine the cancer's stage and guides treatment decisions.
Complications
- The most serious complication of epithelial ovarian cancer is its tendency to spread throughout the abdominal cavity before causing obvious symptoms.
- When cancer cells seed the peritoneum (the lining of the abdomen), they can cause fluid buildup called ascites, bowel obstructions, and difficulty eating.
- These complications can develop gradually over months or more rapidly if the cancer is aggressive.
- Treatment-related complications can also significantly impact quality of life.
- Chemotherapy may cause neuropathy (nerve damage) that affects hands and feet, hearing changes, fatigue, and increased infection risk.
- Surgery, especially extensive debulking procedures, carries risks of bleeding, infection, and damage to surrounding organs.
- Long-term survivors may experience early menopause symptoms, bone density changes, and increased risk of heart disease if treatment included removing the ovaries before natural menopause.
Prevention
- While there's no guaranteed way to prevent epithelial ovarian cancer, several strategies can significantly reduce risk.
- Birth control pills offer one of the most protective effects - women who use them for five or more years cut their risk by about 50%.
- Pregnancy and breastfeeding also provide protection, with risk decreasing with each full-term pregnancy and extended breastfeeding period.
- For women with high genetic risk, particularly those with BRCA mutations, preventive surgery offers the most effective protection.
- Removing the ovaries and fallopian tubes (called risk-reducing bilateral salpingo-oophorectomy) can reduce ovarian cancer risk by 85-95%.
- This surgery is typically recommended after age 35-40 or when childbearing is complete.
- Some women may choose to have their fallopian tubes removed while keeping their ovaries until menopause.
- Regular medical care and genetic counseling can help identify women at higher risk who might benefit from enhanced screening or preventive measures.
- While routine screening isn't recommended for average-risk women, those with strong family histories or genetic mutations may benefit from periodic CA-125 blood tests and transvaginal ultrasounds, though these tests aren't perfect for early detection.
Treatment for epithelial ovarian cancer typically involves a combination of surgery and chemotherapy, with the specific approach depending on the cancer's stage, the patient's overall health, and other individual factors.
Treatment for epithelial ovarian cancer typically involves a combination of surgery and chemotherapy, with the specific approach depending on the cancer's stage, the patient's overall health, and other individual factors. Most women undergo surgery first to remove as much cancer as possible - a procedure called cytoreductive or debulking surgery. This often includes removing both ovaries, the fallopian tubes, the uterus, and any visible cancer deposits throughout the abdomen.
Chemotherapy plays a central role in treating epithelial ovarian cancer.
Chemotherapy plays a central role in treating epithelial ovarian cancer. Most patients receive platinum-based drugs like carboplatin combined with paclitaxel, either after surgery or sometimes before surgery to shrink tumors. The treatment typically involves six cycles given intravenously every three weeks. Some women may receive intraperitoneal chemotherapy, where drugs are delivered directly into the abdominal cavity for more concentrated treatment of cancer cells.
Targeted therapy has revolutionized treatment for certain types of epithelial ovarian cancer.
Targeted therapy has revolutionized treatment for certain types of epithelial ovarian cancer. PARP inhibitors like olaparib, niraparib, and rucaparib work particularly well in women with BRCA mutations or other DNA repair defects. Bevacizumab, which targets blood vessel growth, may be added to chemotherapy for advanced cases. These medications can significantly extend the time before cancer returns.
For recurrent disease, treatment options include different chemotherapy combinations, clinical trials of new drugs, and sometimes additional surgery.
For recurrent disease, treatment options include different chemotherapy combinations, clinical trials of new drugs, and sometimes additional surgery. Immunotherapy is showing promise in clinical trials, and newer targeted drugs are constantly being developed. The key is working with an experienced gynecologic oncology team that can tailor treatment to each woman's specific situation and adjust the plan as needed based on how the cancer responds.
Living With Ovarian Cancer (Epithelial)
Managing life with epithelial ovarian cancer requires building a strong support network and adapting to both physical and emotional challenges. Many women find that connecting with other survivors through support groups provides invaluable practical advice and emotional support. The Cancer Support Community and organizations like SHARE offer both in-person and online resources specifically for ovarian cancer patients.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 12, 2026v1.0.0
- Published page overview and treatments by DiseaseDirectory